Search Results

Modulation of trigeminovascular processing: novel insights into primary headache disorders

Author: Holland, PR

Source: Cephalalgia, Volume 29, Supplement 3, December 2009 , pp. 1-6(6)

Publisher: Blackwell Publishing

Early treatment of acute migraine: new evidence of benefits

Author: Valade, D

Source: Cephalalgia, Volume 29, Supplement 3, December 2009 , pp. 15-21(7)

Publisher: Blackwell Publishing

Eletriptan

Authors: Sandrini, Giorgio; Perrotta, Armando; Tassorelli, Cristina; Nappi, Giuseppe

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 5, Number 12, December 2009 , pp. 1587-1598(12)

Publisher: Informa Healthcare

Expanding Access to Triptans: Assessment of Clinical Outcome

Authors: Cady, Roger K.; Goldstein, Jerome; Silberstein, Stephen; Juhász, Márta; Ramsey, Karen; Rodgers, Anthony; Hustad, Carolyn M.; Ho, Tony

Source: Headache: The Journal of Head and Face Pain, Volume 49, Number 10, November/December 2009 , pp. 1402-1413(12)

Publisher: Blackwell Publishing

Topiramate for Migraine Prevention in a Naturalistic Setting: Results From an Open Label, Flexible Dose Study

Authors: Nelles, Gereon; Delbrück, Anette; Schulze, Lutz; Kademann, Barbara; Bornhoevd, Karin; Schäfer, Susanne; Schäuble, Barbara

Source: Headache: The Journal of Head and Face Pain, Volume 49, Number 10, November/December 2009 , pp. 1454-1465(12)

Publisher: Blackwell Publishing

Maternal characteristics and migraine pharmacotherapy during pregnancy: cross-sectional analysis of data from a large cohort study

Authors: Nezvalová-Henriksen, K; Spigset, O; Nordeng, H

Source: Cephalalgia, Volume 29, Number 12, December 2009 , pp. 1267-1276(10)

Publisher: Blackwell Publishing

Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres

Authors: Cevoli, S; D'Amico, D; Martelletti, P; Valguarnera, F; Del Bene, E; De Simone, R; Sarchielli, P; Narbone, MC; Testa, L; Genco, S; Bussone, G; Cortelli, P

Source: Cephalalgia, Volume 29, Number 12, December 2009 , pp. 1285-1293(9)

Publisher: Blackwell Publishing

Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination

Authors: Cady, Roger K.; Banks, James; Jones, Beverly A.; Campbell, John

Source: Current Medical Research and Opinion, Volume 25, Number 11, November 2009 , pp. 2711-2721(11)

Publisher: Informa Healthcare

Adverse effects of medications commonly used in the treatment of migraine

Authors: Whyte, Chad A; Tepper, Stewart J

Source: Expert Review of Neurotherapeutics, Volume 9, Number 9, September 2009 , pp. 1379-1391(13)

Publisher: Expert Reviews

Safety and Tolerability of Short-Term Preventive Frovatriptan: A Combined Analysis

Authors: MacGregor, E. Anne; Brandes, Jan L.; Silberstein, Stephen; Jeka, Slawomir; Czapinski, Piotr; Shaw, Bob; Pawsey, Stephen

Source: Headache: The Journal of Head and Face Pain, Volume 49, Number 9, October 2009 , pp. 1298-1314(17)

Publisher: Blackwell Publishing

Clinical and Economic Comparison of Frovatriptan Versus other Oral Triptans in the Treatment of Acute Migraine in the Real-World Setting

Authors: Guidotti, Mario; Ravasio, Roberto

Source: Clinical Drug Investigation, Volume 29, Number 11, 1 November 2009 , pp. 693-702(10)

Publisher: Adis International

Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks

Authors: Brandes, JL; Poole, AC; Kallela, M; Schreiber, CP; MacGregor, EA; Silberstein, SD; Tobin, J; Shaw, R

Source: Cephalalgia, Volume 29, Number 11, November 2009 , pp. 1133-1148(16)

Publisher: Blackwell Publishing

Dihydroergotamine: role in the treatment of migraine

Author: Schürks, Markus

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 5, Number 9, September 2009 , pp. 1141-1148(8)

Publisher: Informa Healthcare

EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force

Authors: Evers, S.; Áfra, J.; Frese, A.; Goadsby, P. J.; Linde, M.; May, A.; Sándor, P. S.

Source: European Journal of Neurology, Volume 16, Number 9, September 2009 , pp. 968-981(14)

Publisher: Blackwell Publishing

Fixed-Dose Sumatriptan and Naproxen in Poor Responders to Triptans With a Short Half-Life

Authors: Mathew, Ninan T.; Landy, Stephen; Stark, Stuart; Tietjen, Gretchen E.; Derosier, Frederick J.; White, Jonathan; Lener, Shelly E.; Bukenya, Deo

Source: Headache: The Journal of Head and Face Pain, Volume 49, Number 7, July/August 2009 , pp. 971-982(12)

Publisher: Blackwell Publishing

Revisiting the Efficacy of Sumatriptan Therapy During the Aura Phase of Migraine

Authors: Aurora, Sheena K.; Barrodale, Patricia M.; McDonald, Susan A.; Jakubowski, Moshe; Burstein, Rami

Source: Headache: The Journal of Head and Face Pain, Volume 49, Number 7, July/August 2009 , pp. 1001-1004(4)

Publisher: Blackwell Publishing

The acute treatment of episodic and chronic migraine in the USA

Authors: Bigal, ME; Borucho, S; Serrano, D; Lipton, RB

Source: Cephalalgia, Volume 29, Number 8, August 2009 , pp. 891-897(7)

Publisher: Blackwell Publishing

Telcagepant is a new oral treatment for migraine

Author: Doggrell, Sheila A

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 9, June 2009 , pp. 1523-1526(4)

Publisher: Informa Healthcare

Zelrix™: A Novel Transdermal Formulation of Sumatriptan

Authors: Pierce, Mark; Marbury, Thomas; O'Neill, Carol; Siegel, Steven; Du, Wei; Sebree, Terri

Source: Headache: The Journal of Head and Face Pain, Volume 49, Number 6, June 2009 , pp. 817-825(9)

Publisher: Blackwell Publishing

Analysis of the relationship between age and treatment response in migraine

Authors: Maas, HJ; Danhof, M; Della Pasqua, OE

Source: Cephalalgia, Volume 29, Number 7, July 2009 , pp. 772-780(9)

Publisher: Blackwell Publishing